Heather A. Lankes

Inherited Mutations in Women With Ovarian Carcinoma

Barbara M. Norquist, Maria I. Harrell, Mark F. Brady et al. · JAMA Oncology · 2015 · 764 citations · Full text

Medicine, Genetics, Oncology +17

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

John Farley, William E. Brady, Vinod Vathipadiekal et al. · The Lancet Oncology · 2012 · 413 citations

Medicine, Oncology, Surgery +12

Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study

Dmitriy Zamarin, Robert A. Burger, Michael W. Sill et al. · Journal of Clinical Oncology · 2020 · 351 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study

Barbara M. Norquist, Mark F. Brady, Maria I. Harrell et al. · Clinical Cancer Research · 2017 · 235 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

D. Scott McMeekin, David Tritchler, David E. Cohn et al. · Journal of Clinical Oncology · 2016 · 213 citations

Medicine, Gynecology, Oncology +17